HySum Flexibles Global Management

Management Kriterienprüfungen 4/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Wuhui Lin

Geschäftsführender

CN¥852.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	13.6yrs
Eigentum des Geschäftsführers	30.0%
Durchschnittliche Amtszeit des Managements	14.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.5yrs

Jüngste Management Updates

Recent updates

HySum Flexibles Global (SZSE:300501) Is Paying Out A Larger Dividend Than Last Year

May 24

HySum Flexibles Global's (SZSE:300501) Problems Go Beyond Weak Profit

May 01

There's No Escaping HySum Flexibles Global, Inc.'s (SZSE:300501) Muted Earnings Despite A 26% Share Price Rise

Apr 04

Geschäftsführer

Wuhui Lin (53 yo)

13.6yrs

Amtszeit

CN¥852,000

Vergütung

Mr. Wuhui Lin is Chairman & GM of HySum Flexibles Global, Inc. (formerly known as Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd.), and its Director since November 25, 2010.

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Wuhui Lin	Chairman & GM	no data	CN¥852.00k	29.98% CN¥ 624.3m
Hailong Ni	CFO & Financial Director	19.4yrs	CN¥342.00k	0.12% CN¥ 2.4m
Qin Huang	Chief Investment Officer	no data	CN¥342.00k	0.12% CN¥ 2.5m
Jun Li	VP & Deputy GM	14.1yrs	CN¥870.00k	0.090% CN¥ 1.9m
Ping Chen	VP & Deputy GM	12.4yrs	CN¥700.00k	0.12% CN¥ 2.4m

14.1yrs

Durchschnittliche Betriebszugehörigkeit

53yo

Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von 300501 ist erfahren und erfahren (durchschnittliche Amtszeit: 14 Jahre).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Wuhui Lin	Chairman & GM	13.6yrs	CN¥852.00k	29.98% CN¥ 624.3m
Qin Huang	Chief Investment Officer	4.6yrs	CN¥342.00k	0.12% CN¥ 2.5m
Xiumei Zhu	Non-Independent Director	13.6yrs	CN¥342.00k	16.65% CN¥ 346.8m
Kuanyun Xia	Independent Director	4.6yrs	CN¥60.00k	keine Daten
Shihong Ma	Independent Director	3.5yrs	CN¥60.00k	keine Daten
Jian Gu	Chairman of the Supervisory Board	3.5yrs	keine Daten	keine Daten
Linlin Wang	Independent Director	1.6yrs	CN¥10.00k	keine Daten
Xin Lin	Non-Independent Director	1.6yrs	CN¥260.90k	keine Daten
Yi Zhu	Non-Employee Supervisor	1.6yrs	keine Daten	keine Daten
Ruihua Shi	Staff Supervisor	no data	keine Daten	0.0026% CN¥ 53.7k

3.5yrs

Durchschnittliche Betriebszugehörigkeit

46.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 300501Die Vorstandsmitglieder gelten als erfahren (3.4 Jahre durchschnittliche Amtszeit).

HySum Flexibles Global Management

Management Kriterienprüfungen 4/4

Wichtige Informationen

Jüngste Management Updates

HySum Flexibles Global, Inc., Annual General Meeting, May 08, 2024

High number of new directors

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Board Appointments

High number of new directors

Recent updates

HySum Flexibles Global (SZSE:300501) Is Paying Out A Larger Dividend Than Last Year

Dividend increased to CN¥0.15

HySum Flexibles Global's (SZSE:300501) Problems Go Beyond Weak Profit

HySum Flexibles Global, Inc., Annual General Meeting, May 08, 2024

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.53 in FY 2022)

Investor sentiment deteriorates as stock falls 19%

There's No Escaping HySum Flexibles Global, Inc.'s (SZSE:300501) Muted Earnings Despite A 26% Share Price Rise

Investor sentiment improves as stock rises 17%

HySum Flexibles Global, Inc. to Report Q1, 2024 Results on Apr 25, 2024

HySum Flexibles Global, Inc. (SZSE:300501) announces an Equity Buyback for CNY 100 million worth of its shares.

HySum Flexibles Global, Inc. (SZSE:300501) announces an Equity Buyback for CNY 100 million worth of its shares.

Investor sentiment deteriorates as stock falls 16%

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 18, 2024

Third quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.15 in 3Q 2022)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.081 (vs CN¥0.15 in 2Q 2022)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 16, 2023

First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 1Q 2022)

Investor sentiment improves as stock rises 27%

High number of new directors

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Board Appointments

Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.16 in 2Q 2021)

Upcoming dividend of CN¥0.12 per share

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Approves Cash Dividend for the Year 2021

High number of new directors

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.21 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.09 in 1Q 2020)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Proposes Final Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥0.67 (vs CN¥0.44 in FY 2019)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 16, 2021

New 90-day low: CN¥14.78

Investor sentiment deteriorated over the past week

New 90-day low: CN¥15.35

Investor sentiment deteriorated over the past week

New 90-day low: CN¥19.63

New 90-day low: CN¥20.23

Third quarter earnings released

Market bids up stock over the past week

First half earnings released

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥34.70

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter